Skip to main content

Table 3 Median survival of patients with esophageal cancer diagnosed at AUBMC between 1995 and 2019

From: Esophageal cancer: a twenty-four-year experience at a tertiary care center with an evaluation of the prognostic significance of the neutrophil-lymphocyte ratio

Factor

Variable

Median survival in months (IQR)

p value

Date of diagnosis n = 97

< 2010

4 (1–17.8)

0.186

> 2010

10 (4–32.5)

Location n = 93

Upper + Middle

6.5 (2–13.5)

0.395

Lower + GE junction

9 (3–30)

Type n = 97

SCC

7 (2–25)

.803

AC

9 (3–26.3)

Tumor grade n = 85

Poorly differentiated

4 (1.5–22.5)

.851

Moderately differentiated

9 (3–25.5)

Well differentiated

5 (1.8–41.3)

Stage n = 76

Stage 1

45 (1–69)

.037

Stage 2

3 (1.3–6)

Stage 3

12 (4–28)

Stage 4

6.5 (3–26.5)

  1. Median survival – months (IQR): 9 (3.0–25.5), n = 97 patients